肝纤维化的发病机制及治疗新靶点
近年来,肝纤维化的基础研究进展非常迅速。简单回顾了肝纤维化的细胞和分子发病机制,主要包括肌成纤维细胞的来源、免疫调节、自噬、表观调节。同时简要介绍了肝纤维化的几种治疗策略,为肝纤维化的治疗提供新的治疗靶点,分析表明祛除病因是目前最重要的抗肝纤维化治疗方法。尽管目前已经出现了针对不同靶点的抗纤维化药物,但大多数还处于早期研发阶段,尚需经过严格的临床研究才能确认其疗效。...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 33; no. 3; pp. 409 - 412 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
首都医科大学附属北京友谊医院肝病中心,北京,100050
2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 近年来,肝纤维化的基础研究进展非常迅速。简单回顾了肝纤维化的细胞和分子发病机制,主要包括肌成纤维细胞的来源、免疫调节、自噬、表观调节。同时简要介绍了肝纤维化的几种治疗策略,为肝纤维化的治疗提供新的治疗靶点,分析表明祛除病因是目前最重要的抗肝纤维化治疗方法。尽管目前已经出现了针对不同靶点的抗纤维化药物,但大多数还处于早期研发阶段,尚需经过严格的临床研究才能确认其疗效。 |
|---|---|
| AbstractList | R575.2; 近年来,肝纤维化的基础研究进展非常迅速.简单回顾了肝纤维化的细胞和分子发病机制,主要包括肌成纤维细胞的来源、免疫调节、自噬、表观调节.同时简要介绍了肝纤维化的几种治疗策略,为肝纤维化的治疗提供新的治疗靶点,分析表明祛除病因是目前最重要的抗肝纤维化治疗方法.尽管目前已经出现了针对不同靶点的抗纤维化药物,但大多数还处于早期研发阶段,尚需经过严格的临床研究才能确认其疗效. 近年来,肝纤维化的基础研究进展非常迅速。简单回顾了肝纤维化的细胞和分子发病机制,主要包括肌成纤维细胞的来源、免疫调节、自噬、表观调节。同时简要介绍了肝纤维化的几种治疗策略,为肝纤维化的治疗提供新的治疗靶点,分析表明祛除病因是目前最重要的抗肝纤维化治疗方法。尽管目前已经出现了针对不同靶点的抗纤维化药物,但大多数还处于早期研发阶段,尚需经过严格的临床研究才能确认其疗效。 |
| Abstract_FL | In recent years,the basic research on liver fibrosis has been progressed rapidly.This article briefly reviews the cellular and molecular mechanisms of liver fibrosis,including the origin of myofibroblasts,immune regulation,autophagy,and epigenetic regulation,and introduces several new therapeutic targets.More and more evidences show that successful removal of causes is the most important antifibrotic therapy.At present,although the antifibrotic drugs acting on different targets have been emerging,most of them are still in the early stage of research and development,and well-designed clinical trials are needed to confirm their clinical efficacy. |
| Author | 张伟 贾继东 |
| AuthorAffiliation | 首都医科大学附属北京友谊医院肝病中心,北京100050 |
| AuthorAffiliation_xml | – name: 首都医科大学附属北京友谊医院肝病中心,北京,100050 |
| Author_FL | ZHANG Wei JIA Jidong |
| Author_FL_xml | – sequence: 1 fullname: ZHANG Wei – sequence: 2 fullname: JIA Jidong |
| Author_xml | – sequence: 1 fullname: 张伟 贾继东 |
| BookMark | eNo9j8tKw0AYhWdRwVr7EuLCTeJcnD8zSyneoOCm-zCZZGJKnWiCiF0WBRGhuGlB7M4HEJGC7fMk0bcwUnF14OPjHM4GatjURghtE-wyCXK37yZ5bl2CMXE45eBSTDwXM7cGDdT85-uonedJgDlhIPc4NJHzNZpVi9dq-VE8Tqrn22L8VE3vypdFcT8vxg_l-7KaTMvJ2_dsXo0-N9GaUYM8av9lC_UOD3qdY6d7enTS2e86GuolRT1qIDIBByUiHUrQKvS4ItoIo6jWEQMGASNYK09KTImhnDPuRUQQpQ1roZ1V7bWyRtnY76dXma0H_YGOw2A4_L2HWf2qVrdWqj5LbXyZ1PJFlpyr7MYHj4AAIQT7AYaAZLk |
| ClassificationCodes | R575.2 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2017.03.001 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Pathogenesis and new therapeutic targets of liver fibrosis |
| DocumentTitle_FL | Pathogenesis and new therapeutic targets of liver fibrosis |
| EndPage | 412 |
| ExternalDocumentID | lcgdbzz201703001 671686888 |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c601-a272f6efb56a8ecd96cad75a1cf8fa2cce3636b310ca799021f255357e181acf3 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:50 EDT 2025 Wed Feb 14 10:03:32 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | editorial 治疗 述评 肝硬化 therapy liver cirrhosis |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c601-a272f6efb56a8ecd96cad75a1cf8fa2cce3636b310ca799021f255357e181acf3 |
| Notes | ZHANG Wei, JIA Jidong. （Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China） In recent years,the basic research on liver fibrosis has been progressed rapidly.This article briefly reviews the cellular and molecular mechanisms of liver fibrosis,including the origin of myofibroblasts,immune regulation,autophagy,and epigenetic regulation,and introduces several new therapeutic targets.More and more evidences show that successful removal of causes is the most important antifibrotic therapy.At present,although the antifibrotic drugs acting on different targets have been emerging,most of them are still in the early stage of research and development,and well-designed clinical trials are needed to confirm their clinical efficacy. liver cirrhosis; therapy; editorial 22-1108/R |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201703001 chongqing_primary_671686888 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2017 |
| Publisher | 首都医科大学附属北京友谊医院肝病中心,北京,100050 |
| Publisher_xml | – name: 首都医科大学附属北京友谊医院肝病中心,北京,100050 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 2.061519 |
| Snippet | ... R575.2;... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 409 |
| SubjectTerms | 治疗 肝硬化 述评 |
| Title | 肝纤维化的发病机制及治疗新靶点 |
| URI | http://lib.cqvip.com/qk/90100X/201703/671686888.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201703001 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RAdFhbKF7ET6xVqdA5SWo-JpOZY7KbpQj1tEJvy2SSaQ-y9WO97M2iICIUL1sQe_MHiEjB9vfsrv4L30um2VSkqJcwvHl582be5H0M814IWQvB6nHBAsc1mjlMR4UjlGJO5ObMBL7RIsOjgc1HfOMxe7gVbrVar5rZJcNsXY_-mFfyP1IFGMgVs2T_QbI1UQBAG-QLT5AwPP9KxjQVVPhUdmga0SSmMSsbCU2gEVLRppIjRMZUVJAulV4JiagIacqpbOOL2CVowi2OiLEr8ZEUInPER2QAujSVOGJSUobRE9l0cGnKaCIsA0AZSdVMQiOggp9loIO9iAy81UaxBLRp7Jb0YB7d-_g6kE1SO8c4smPJdvPoosrRtHoWb3KFflVT_FQRVxUx7IYLGlqVubJhoFl17_p33Q97Tpa6HwdYrwfA23tRVcfWm9u8-iYih3hRcCHEBbLoQ6QBun0xTjpJd-5Teu6Zgj-YedzwebFgP2vUBAy9gEs2L1AUgseKVRJP3QPmSVFlfVgGl8ia5f7Bebxj7Y-d3cH2M_BoygSzgVGD7YYv1LtMLtkgZjWuduQV0hrtXCVLm_aaxjXi_Ng7nB1_np18m7wfzz6-nux_mB28mX46nrw9muy_m349mY0PpuMvPw-PZnvfr5NeN-21Nxz7Xw5HQ_juKD_yDS9MFnIlCp1LrlUehcrTRhjla10EPOAZxA1aReDs-J6BuDUIowK8SaVNcIMsDHYHxU2ymud-Hga5CXSRMU-5yssyF9bUl1GmJTPLZKWedP9pVX6lX4tsmdyzy9C3H-WL_hO9nWejES4cmC_Xu3UuhRVyETGrI7XbZGH4_GVxB5zMYXbXboNfYsZeJQ |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%82%9D%E7%BA%A4%E7%BB%B4%E5%8C%96%E7%9A%84%E5%8F%91%E7%97%85%E6%9C%BA%E5%88%B6%E5%8F%8A%E6%B2%BB%E7%96%97%E6%96%B0%E9%9D%B6%E7%82%B9&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%BC%A0%E4%BC%9F+%E8%B4%BE%E7%BB%A7%E4%B8%9C&rft.date=2017&rft.issn=1001-5256&rft.volume=33&rft.issue=3&rft.spage=409&rft.epage=412&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2017.03.001&rft.externalDocID=671686888 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |